1. Introduction
Molecular docking is a frequently employed bioinformatics method that is capable of predicting with great accuracy (when the initial structure preparation is done properly) the conformation of small molecular weight ligands (Latin
2. What advantages did molecular docking technique offer us?
In the last two decades, molecular docking has found significant use in the discipline of molecular biology in addition to structure-based drug design (SBDD). For instance, while the molecular docking method predicts the interactions between enzymes and their substrates, quite accurately in terms of binding free energy and conformation [12, 13, 14, 15], it has also proven its ability to calculate the negative functional effects of induced mutations in proteins as well as the effects of naturally occurring point mutations on enzyme-substrate binding [16, 17, 18, 19]. Thus, molecular docking offers a powerful option for investigating the correlation between structure and function. While the utilization of molecular docking in biochemistry is generally aimed at confirming data related to enzyme inhibitory activity, such as experimental dissociation constant (Kd) or half-maximal inhibitory concentration (IC50) [20, 21, 22, 23, 24], in microbiology, it is widely used to theoretically verify the minimum inhibitory concentration (MIC) values of natural herbal extracts or synthetic components targeted against bacterial enzymes [25, 26, 27, 28, 29]. Recently, although molecular docking programs have not been specifically designed to characterize ligand-DNA interactions, the molecular docking method has now been frequently used to predict the binding modes and affinity of small molecules on DNA, especially in genotoxicity studies [30, 31, 32, 33, 34, 35]. Last but not least, the inherent nature of molecular docking, which is based on biochemistry and biophysics, has allowed it to take place even in the COVID-19 pandemic, which has severely affected the world agenda, societies, and the global economy for about 2 years. This method has ultimately become a principle component in bioinformatics-based drug-discovery campaigns against the SARS-CoV-2 virus [36, 37, 38, 39, 40, 41].
3. Molecular docking is in principle closely connected with molecular dynamics simulations
As commonly known, intracellular receptor-ligand interactions are dynamic phenomena by nature, where ions and water molecules in this milieu have undeniable importance during these intermolecular reactions. At the same time, the inherent flexibility of the interacting protein partners and ligands is an important variable that has to be taken into account in docking calculations. Therefore, considering these variables, molecular docking techniques have evolved further over time and new docking algorithms (ex. flexible receptor-flexible ligand docking or solvated docking) have been developed to produce more accurate receptor-ligand poses [42, 43, 44, 45]. However, simulating the movements of all types of atoms around the reaction site is still beyond the limits of the molecular docking technique. In this context, the molecular dynamics simulations have proved to be indispensable molecular interaction simulation methods used as a complement to the molecular docking technique in order to study the receptor-ligand binding dynamics and the time-dependent evolution of the resulting complex. Therefore, the molecular docking technique should be supported by molecular dynamics simulations, regardless of which biological problem it is used to solve.
4. Conclusion
A feature of biological macromolecules or synthetic chemical compounds is that the basic building blocks come together to form larger building blocks, which then come together to form even larger structures, and the process continues in the same way. The structure and function of these macromolecules composed of small monomers are frequently quite different from the building blocks that compose them, and such phenomena are referred as ‘
References
- 1.
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015; 20 (7):13384-13421 - 2.
Morris GM, Lim-Wilby M. Molecular docking. In: Kukol A, editor. Molecular Modeling of Proteins. Totowa, NJ: Humana; 2008. pp. 365-382 - 3.
Pagadala NS, Syed K, Tuszynski J. Software for molecular docking: A review. Biophysical Reviews. 2017; 9 (2):91-102 - 4.
Gschwend DA, Good AC, Kuntz ID. Molecular docking towards drug discovery. Journal of Molecular Recognition: An Interdisciplinary Journal. 1996; 9 (2):175-186 - 5.
Fan J, Fu A, Zhang L. Progress in molecular docking. Quantitative Biology. 2019; 7 (2):83-89 - 6.
Dias R, de Azevedo J, Walter F. Molecular docking algorithms. Current Drug Targets. 2008; 9 (12):1040-1047 - 7.
Sethi A, Joshi K, Sasikala K, Alvala M. Molecular docking in modern drug discovery: Principles and recent applications. Drug discovery and Development-New Advances. 2019; 2 :1-21 - 8.
Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins: Structure, Function, and Bioinformatics. 2002; 47 (4):409-443 - 9.
Yuriev E, Holien J, Ramsland PA. Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. Journal of Molecular Recognition. 2015; 28 (10):581-604 - 10.
Andrusier N, Mashiach E, Nussinov R, Wolfson HJ. Principles of flexible protein–protein docking. Proteins: Structure, Function, and Bioinformatics. 2008; 73 (2):271-289 - 11.
Prieto-Martínez FD, Arciniega M, Medina-Franco JL. Molecular docking: Current advances and challenges. TIP. Revista especializada en ciencias químico-biológicas. 2018; 21 (Suppl. 1):65-87 - 12.
Luniwal A, Wang L, Pavlovsky A, Erhardt PW, Viola RE. Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase. Bioorganic & Medicinal Chemistry. 2012; 20 (9):2950-2956 - 13.
Rudnitskaya A, Török B, Török M. Molecular docking of enzyme inhibitors: A computational tool for structure-based drug design. Biochemistry and Molecular Biology Education. 2010; 38 (4):261-265 - 14.
Udatha DBRK, Sugaya N, Olsson L, Panagiotou G. How well do the substrates KISS the enzyme? Molecular docking program selection for feruloyl esterases. Scientific Reports. 2012; 2 (1):1-8 - 15.
Burmaoglu S, Kazancioglu EA, Kazancioglu MZ, Sağlamtaş R, Yalcin G, Gulcin I, et al. Synthesis, molecular docking and some metabolic enzyme inhibition properties of biphenyl-substituted chalcone derivatives. Journal of Molecular Structure. 2022; 1254 :132358 - 16.
Karaytuğ T, Arabacı N, İstifli ES. Microbial and bioinformatics approach in biofuel production. In: Bioenergy Research: Basic and Advanced Concepts. Singapore: Springer; 2021. pp. 257-306 - 17.
Yu J, Shi J, Zhang Y, Yu Z. Molecular docking and site-directed mutagenesis of dichloromethane dehalogenase to improve enzyme activity for dichloromethane degradation. Applied Biochemistry and Biotechnology. 2020; 190 (2):487-505 - 18.
Chiappori F, D’Ursi P, Merelli I, Milanesi L, Rovida E. In silico saturation mutagenesis and docking screening for the analysis of protein-ligand interaction: The Endothelial Protein C Receptor case study. BMC Bioinformatics. 2009; 10 (12):1-8 - 19.
Go MK, Zhao LN, Xue B, Supekar S, Robinson RC, Fan H, et al. Directed computational evolution of quorum-quenching lactonases from the amidohydrolase superfamily. Structure. 2020; 28 (6):635-642 - 20.
Deepa PR, Vandhana S, Muthukumaran S, Umashankar V, Jayanthi U, Krishnakumar S. Chemical inhibition of fatty acid synthase: Molecular docking analysis and biochemical validation in ocular cancer cells. Journal of Ocular Biology, Diseases, and Informatics. 2010; 3 (4):117-128 - 21.
Mathew B, Mathew GE, Uçar G, Baysal I, Suresh J, Vilapurathu JK, et al. Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorganic Chemistry. 2015; 62 :22-29 - 22.
Günsel A, Yıldırım A, Taslimi P, Erden Y, Taskin-Tok T, Pişkin H, et al. Cytotoxicity effects and biochemical investigation of novel tetrakis-phthalocyanines bearing 2-thiocytosine moieties with molecular docking studies. Inorganic Chemistry Communications. 2022; 138 :109263 - 23.
Taj S, Ahmad M, Ashfaq UA. Exploring of novel 4-hydroxy-2H-benzo [e][1, 2] thiazine-3-carbohydrazide 1, 1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study. International Journal of Biological Macromolecules. 2022; 207 :507-521 - 24.
Rehman SU, Sarwar T, Ishqi HM, Husain MA, Hasan Z, Tabish M. Deciphering the interactions between chlorambucil and calf thymus DNA: A multi-spectroscopic and molecular docking study. Archives of Biochemistry and Biophysics. 2015; 566 :7-14 - 25.
Emran TB, Rahman MA, Uddin MMN, Dash R, Hossen MF, Mohiuddin M, et al. Molecular docking and inhibition studies on the interactions of Bacopa monnieri’s potent phytochemicals against pathogenic Staphylococcus aureus. DARU Journal of Pharmaceutical Sciences. 2015; 23 (1):1-8 - 26.
Pisano MB, Kumar A, Medda R, Gatto G, Pal R, Fais A, et al. Antibacterial activity and molecular docking studies of a selected series of hydroxy-3-arylcoumarins. Molecules. 2019; 24 (15):2815 - 27.
Damasceno JPL, Rodrigues RP, Goncalves RDCR, Kitagawa RR. Anti-Helicobacter pylori activity of isocoumarin paepalantine: Morphological and molecular docking analysis. Molecules. 2017; 22 (5):786 - 28.
Cheng K, Zheng QZ, Qian Y, Shi L, Zhao J, Zhu HL. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics. Bioorganic & Medicinal Chemistry. 2009; 17 (23):7861-7871 - 29.
Rana KM, Maowa J, Alam A, Dey S, Hosen A, Hasan I, et al. In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer properties. In Silico Pharmacology. 2021; 9 (1):1-24 - 30.
Husunet MT, Mısırlı RÇ, Istifli ES, Ila HB. Investigation of the genotoxic effects of patent blue V (E131) in human peripheral lymphocytes and in silico molecular docking. Drug and Chemical Toxicology. 2021:1-7 - 31.
Liman R, Ali MM, Ciğerci İH, İstifli ES, Sarikurkcu C. Cytotoxic and genotoxic evaluation of copper oxychloride through Allium test and molecular docking studies. Environmental Science and Pollution Research. 2021; 28 (33):44998-45008 - 32.
Liman R, Ali MM, Istifli ES, Ciğerci İH, Bonciu E. Genotoxic and cytotoxic effects of pethoxamid herbicide on Allium cepa cells and its molecular docking studies to unravel genotoxicity mechanism. Environmental Science and Pollution Research. 2022. DOI: 10.1007/s11356-022-20166-5 - 33.
Ince Yardimci A, Istifli ES, Acikbas Y, Liman R, Yagmucukardes N, Yilmaz S, et al. Synthesis and characterization of single-walled carbon nanotube: Cyto-genotoxicity in Allium cepa root tips and molecular docking studies. Microscopy Research and Technique. DOI: 10.1002/jemt.24177 - 34.
Liman R, Kursunlu AN, Ozmen M, Arslan S, Mutlu D, Istifli ES, et al. Synthesis of water soluble symmetric and asymmetric pillar [5] arene derivatives: Cytotoxicity, apoptosis and molecular docking studies. Journal of Molecular Structure. 2022; 1265 :133482 - 35.
İstifli ES. Preliminary in silico studies of the interactions of certain genotoxic azo dyes with different double-stranded DNA conformations. Colorants. 2022; 1 (2):236-255 - 36.
Istifli ES, Netz PA, Sihoglu-Tepe A, Husunet MT, Sarikurkcu C, Tepe B. In silico analysis of the interactions of certain flavonoids with the receptor-binding domain of 2019 novel coronavirus and cellular proteases and their pharmacokinetic properties. Journal of Biomolecular Structure & Dynamics. 2022; 40 (6):2460-2474 - 37.
Istifli ES, Netz PA, Sihoglu-Tepe A, Sarikurkcu C, Tepe B. Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2). Journal of Biomolecular Structure & Dynamics. 2021:1-12 - 38.
Kong R, Yang G, Xue R, Liu M, Wang F, Hu J, et al. COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19. Bioinformatics. 2020; 36 (20):5109-5111 - 39.
Sharma AD, Kaur I. Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection. arXiv preprint arXiv:2004.00217. 2020 - 40.
Suravajhala R, Parashar A, Malik B, Nagaraj AV, Padmanaban G, Kavi-Kishor P, et al. Comparative docking studies on curcumin with COVID-19 proteins. Preprints. 2020:2020050439. doi: 10.20944/preprints202005.0439.v1 - 41.
Schuller M, Correy GJ, Gahbauer S, Fearon D, Wu T, Díaz RE, et al. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Science Advances. 2021; 7 (16):eabf8711 - 42.
Wei BQ , Weaver LH, Ferrari AM, Matthews BW, Shoichet BK. Testing a flexible-receptor docking algorithm in a model binding site. Journal of Molecular Biology. 2004; 337 (5):1161-1182 - 43.
Wong CF. Flexible receptor docking for drug discovery. Expert Opinion on Drug Discovery. 2015; 10 (11):1189-1200 - 44.
Barril X, Morley SD. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. Journal of Medicinal Chemistry. 2005; 48 (13):4432-4443 - 45.
Zhao Y, Sanner MF. FLIPDock: Docking flexible ligands into flexible receptors. Proteins: Structure, Function, and Bioinformatics. 2007; 68 (3):726-737